Business
Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria
Led by Prof. Dr. Marianne Brodmann, PI of clinical studies for the Lumee™ Oxygen CE Mark, collaboration includes practice adoption and platform integration in
About this update from Profusa, Inc.
[{"type":"text","content":"Led by Prof. Dr. Marianne Brodmann, PI of clinical studies for the Lumee™ Oxygen CE Mark, collaboration includes practice adoption and platform integration in cases and clinical study programs BERKELEY, Calif, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual’s biochemistry, announces a commercial and clinical collaboration with Prof. Dr. Marianne Brodmann at the Medical University of Graz, Austria. Under the collaboration, Prof. Brodmann will adopt the Lumee oxygen platform technology in her practice of approximately 1,500 annual vascular procedures. In addition, as principal investigator (PI) of clinical studies that supported Lumee oxygen in its CE marking, Prof. Brodmann intends to integrate Profusa’s platform technology in cases and clinical study programs. \"Real-time oxygen perfusion data for patients suffering from critical limb ischemia is critical for the proper monitoring of patients during surgery and as they recover,\" said Prof. Brodmann. \"As an experienced user of Profusa's technology through leading portions of Profusa's clinical studies, I am convinced that the Lumee Oxygen platform meets an important clinical need. I am excited to adopt the Lumee Oxygen system to improve patient outcomes and continue to explore ways for clinical communities to use Lumee Oxygen to improve patient care.\" Prof. Dr. Marianne Brodmann is a board member of the European Union of Medical Specialists and a fellow at the European Society of Cardiology (ESC). She served as the president of the Austrian Society of Angiology, a national delegate for the International Union of Angiology, and had been a member of various groups such as ESC Working Group on Aorta & Peripheral Vascular Diseases and Nucleus ÖGIA. She has been involved with more than 50 international trials, researching, among many topics, anticoagulation, thrombolysis, restenosis, and new technologies in the endovascular field. Prof. Brodmann has over 100 publications listed on PubMed Central. \"Our continued collaboration with Prof. Brodmann and the Medical University of Graz, Austria provides additional validation for our Lumee technology platform, and we are proud to add the practice to...